J Am Heart Assoc. 2026 Feb 27:e044323. doi: 10.1161/JAHA.125.044323. Online ahead of print.
ABSTRACT
BACKGROUND: Tricuspid regurgitation (TR) is a common valvular disorder that can affect patients' quality of life and survival. The impact of TR etiology on overall survival and the associated risk factors in each subgroup are not well studied.
METHODS: Multisite, retrospective study evaluating survival based on TR etiology using Kaplan-Meier and Cox regression models. Stepwise approach was used to define TR etiology (≥moderate): primary (PTR; presence of a primary valvular pathology), lead associated (LTR; lead interfering with closure), and secondary TR (STR) in the setting of left-sided valvular disease, left ventricular disease, other causes of pulmonary hypertension, right ventricular disease, and atrial secondary TR.
RESULTS: A total of 12 899 patients were included (3% PTR, 90% STR, 7% LTR). The mean age was 68±14, 73±13, and 71±13 years, respectively (44%-55% female patients). Adjusting for age, sex, and TR severity, patients with PTR had better overall survival (PTR: reference; STR hazard ratio [HR], 1.4 [1.2-1.6], LTR HR, 1.5 [1.1-1.7]). On multivariable Cox regression, the Tricuspid Regurgitation Impact on Outcomes score was associated with mortality across all groups (P<0.05 for all). In addition, other risk factors associated with worse outcomes included pulmonary hypertension and ≥moderate right ventricular enlargement in PTR; left-sided valvular disease, pulmonary hypertension, and ≥moderate right ventricular dysfunction in STR; and left ventricular disease and ≥moderate right ventricular dysfunction in LTR.
CONCLUSIONS: Patients with PTR have better survival than STR and LTR. Tricuspid Regurgitation Impact on Outcomes score was associated with mortality across etiologies, whereas other risk factors are etiology specific. Improved risk profiling may enhance patient selection, treatment decisions, and outcomes.
PMID:41757445 | DOI:10.1161/JAHA.125.044323